Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Recombinant Proteins & Antibodies

SARS-CoV-2 Mutants

Emerging VoCs, Omicron, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.

GMP Grade Cytokines

ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.

Targets of CAR-T Cell Therapy

50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.                  

Discovery Solutions for CGT

GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.

Targets for ADCs

To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.

BsAb targets

CD3 proteins and a collection of for bispecific antibody development which are of high specificity and bioactivities and suitable for immunization, antibody screening.

Immune Checkpoints

A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.

Full-length Transmembrane Proteins

Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.

Fc Receptors

Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.

MABSOL® Biotinylated Proteins

The MABSOL biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.

Cytokines

Comprehensive cytokines including IL families, growth factors, chemokines, TNFs, etc. These products are HEK293 expressed and nearly in authentic structure, high purity and bioactivity, cell based assay/SPR/BLI verified.

Anti-idiotypic Antibodies

To support preclinical/clinical immunogenicity and PK analysis, ACROBiosystems has developed a series of high-affinity anti-idiotypic antibodies. Our pipeline covers five hot targets including adalimum*b, rituxim*b, cetuxim*b, trastuzum*b, and bevacizum*b.

Newly Added Products

Mutants from SARS-CoV-2 Emerging Variants Omicron and more

ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.

GMP Grade Cytokines

ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.

News Center

[Inspiring Target] Therapeutic Potential of Complement in Inflammation, Cancer, and COVID-19
2022/05/16
[Inspiring Target] Therapeutic Potential of Complement in Inflammation, Cancer, and COVID-19
The complement system, also known as the complement cascade, is an essential part of the innate immune system and plays a crucial role in defense against microbial infection and clearance of immune complexes and injured cells. Despite the lack of specificity of the components of the acquired immune
Learn more
LILRB + HLA-G, A New Ground-breaking Immunotherapy Combination
2022/05/16
LILRB + HLA-G, A New Ground-breaking Immunotherapy Combination
Immune-Onc Therapeutics released their research of io-108, a novel clinical-stage myeloid checkpoint inhibitor targeting LILRB2 (ILT4), at the American Association for Cancer Research (AACR) 2022 Annual Meeting. IO-108 promotes innate and adaptive anti-cancer immunity in preclinical models, and it i
Learn more
Congratulations to ACROBiosystems being Listed on domestic Shenzhen Stock Exchange
2021/10/21
Congratulations to ACROBiosystems being Listed on domestic Shenzhen Stock Exchange
ACROBiosystems is pleased to announce that on October 18, 2021 Beijing local time, the company was listed onthe Shenzhen Stock Exchange.
Learn more
Biomarkers UK
2023/05/03 - 2023/04/04
Biomarkers UK
Speaker: ACROBiosystems
Time: May 3rd-4th, 2022
Learn more

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message